This mRNA vaccine production facility, built from recycled shipping containers, should eventually employ around 100 people, on a 35,000 square meter site. This is Africa’s second mRNA vaccine plant, following an initial partnership in South Africa between biotech companies Afrigen and Biovac, supported by the WHO and the South African Medical Research Council.
